Aster DM Quality Care
Stock Snapshot
Price Performance
Vista Outlook
Basis of our Recommendation
Aster DM Quality Care's recent developments underscore a robust growth trajectory, driven by management's strategic focus on integrating its recent merger with Quality Care India and expanding its healthcare capacity. The company aims to leverage its strong brand presence in South India while executing a significant expansion plan that includes adding over 4,000 beds by FY30. This initiative is expected to enhance revenue growth, supported by increasing demand for high-acuity medical services. Management's disciplined capital allocation strategy, prioritizing brownfield expansions, is designed to optimize returns and maintain stable profit margins. Despite potential headwinds from integration challenges and rising operational costs, Vista's financial outlook anticipates a 22.66% upside, with stable margins projected at 24-25% by FY28-29. The healthcare sector's favorable dynamics, including rising insurance coverage and demand for organized care, further bolster Aster's position. However, the company must navigate risks related to execution and competitive pressures in urban markets. Over the next 12-24 months, key opportunities lie in operational excellence and successful integration, while watchpoints include managing costs and sustaining growth in a competitive landscape
Why We Like This Stock
- Management's focus on integrating the merger with Quality Care India is expected to unlock significant operational synergies and enhance scale
- The aggressive expansion plan aims to add over 4,000 beds, capitalizing on the increasing demand for high-acuity healthcare services
- Stable profit margins are projected, supported by disciplined capital allocation and a favorable shift in service offerings
Things To Watch Out For
- Execution risks related to the integration of the merged entities could impact operational efficiency and profitability
- Rising operational costs, particularly in human capital, may pressure margins if not managed effectively
- Intense competition in urban markets poses a challenge to maintaining market share and pricing power
Key Parameters
Financial Snapshot
View Technicals Analysis →| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 3,699 | 4,138 | 4,643 | 5,104 | 6,478 |
| Profit Before Tax (Cr.) | 261 | 512 | 603 | 694 | 907 |
| PBT Margin | 7.1% | 12.4% | 13.0% | 13.6% | 14.0% |
| Net Profit (Cr.) | 235 | 310 | 409 | 468 | 553 |
| Earnings Per Share | 3.0 | 5.4 | 7.1 | 8.2 | 10.7 |
Analyst Recommendations
| Broker | Recommendation | Target Price | Date |
|---|---|---|---|
| Motilal Oswal | ▲ Buy | 910 | 28-Sep-2026 |
| HDFC Securities | ► Add | 910 | 06-Aug-2026 |
| ICICI Securities | ▲ Buy | 895 | 06-Aug-2026 |
| Prabhudas Liladhar | ▲ Buy | 920 | 06-Aug-2026 |
| HSBC | ▲ Buy | 785 | 04-May-2026 |
| Elara Capital | ► Accumulate | 736 | 02-May-2026 |
Company Overview
Show Company Profile
Aster DM Quality Care Limited operates as an integrated healthcare provider in India. The company operates through four healthcare brands including Aster DM, CARE Hospitals, Evercare, and KIMSHEALTH. It offers comprehensive healthcare services including primary, secondary, tertiary and quaternary care across key areas including oncology, cardiac sciences, neurosciences, gastro sciences, orthopedics, nephrology, organ transplantation, mother and childcare, and critical care. In addition, the company operates retail pharmacies and optical outlets. Aster DM Quality Care Limited was formerly known as Aster DM Healthcare Limited and changed its name to Aster DM Quality Care Limited in July 2026. The company was founded in 1987 and is based in Hyderabad, India.